Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Interferon-Induced Fatigue in Melanoma
NCT00003266Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Oct 1999
- Primary completion
- May 2002
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of methylphenidate in fatigue, lethargy, sponsored by Eastern Cooperative Oncology Group. Started Oct 1999; status: completed.
02
Drugs
methylphenidate
03
Conditions
fatiguelethargy
Beyond the preview
Go deeper on NCT00003266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003266.